C. Emmanouilides

Randomized, Multicenter, Open-Label Study of Pegfilgrastim Compared With Daily Filgrastim After Chemotherapy for Lymphoma

Julie Vose, Michael Crump, H M Lazarus et al. · Journal of Clinical Oncology · 2003 · 187 citations

Medicine, Oncology, Pharmacokinetics +16

Association of the advanced lung cancer inflammation index (ALI) with immune checkpoint inhibitor efficacy in patients with advanced non-small-cell lung cancer

Giannis Mountzios, Epaminontas Samantas, K. Senghas et al. · ESMO Open · 2021 · 94 citations · Full text

Medicine, Oncology, Pharmacology +17

Anti-VEGF antibody bevacizumab (Avastin) with 5FU/LV as third line treatment for colorectal cancer

C. Emmanouilides, Mark D. Pegram, R. Robinson et al. · Techniques in Coloproctology · 2004 · 40 citations

Medicine, Oncology, Pharmacotherapy +15

Combination Therapy with Rituximab and Fludarabine in Waldenstrom’s Macroglobulinemia.

Steven P. Treon, Andrew R. Branagan, Parveen Wasi et al. · Blood · 2004 · 18 citations

Life Sciences, Immunology, Pharmacotherapy +12